Cystic Fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. It is caused by a mutation in the CFTR gene, which leads to the production of thick, sticky mucus in the body. This mucus clogs the airways, making it difficult to breathe and increasing the risk of lung infections. CF also affects the pancreas, preventing the release of digestive enzymes needed to break down food and absorb nutrients.
Symptoms of CF can vary, but commonly include persistent coughing, frequent lung infections, poor growth and weight gain, and salty-tasting skin. The severity of the condition can vary from person to person, with some individuals experiencing mild symptoms while others face more severe complications.
CF is a lifelong condition that requires ongoing management and treatment. This typically involves a combination of medications, airway clearance techniques, and nutritional support. Regular monitoring and medical care are crucial to prevent and manage complications.
Research and advancements in treatment have significantly improved the quality of life and life expectancy for individuals with CF. However, it remains a challenging condition that requires comprehensive care and support.